InvestorsHub Logo
Followers 7
Posts 1233
Boards Moderated 0
Alias Born 09/23/2009

Re: The_Free_Nebula post# 6774

Wednesday, 04/01/2015 10:00:04 AM

Wednesday, April 01, 2015 10:00:04 AM

Post# of 27409
Let me explain myself.

Market size is increasing, distributors are increasing, sales people were increasing and time was increasing. All of these things by themselves should lead to greater sales revenue. However, CTSO stated that Q4 2014, Q1 2015 and Q2 2015 (essentially 9 FREAKING MONTHS) will be flat with revenue growth.

GUY - THAT IS ALMOST 1 YEAR OF NO REVENUE GROWTH!!!

How can that POSSIBLY BE ON A NEW BREAKTHROUGH PRODUCT? That answer is that it can't be. I have followed this stock RELIGOUSLY for 5 years. I held 6.7M shares, as shown on my Scottrade account on this very message board, for a long period of time. Yes most of that was to trade the stock and yes I did make a killing time and time over again by manipulating price on a low volume OTC stock. However, I was ALWAYS LONG AND STRONG CTSO. There may be times I was a critic, but at those times I was still a believer. Something is wrong that revenues are flat for 9 months on a new innovative product. My guess is that the products works to filter cytokines out of the blood (which it has shown to do) however, their original thesis that this would lead to faster recovery time in the ICU or less death in patients treated HAS NOT BEEN PROVEN.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News